POZEN (POZN) Sells Treximet Rights in $75M Deal (GSK)
Go back to POZEN (POZN) Sells Treximet Rights in $75M Deal (GSK)| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,404,769 | |||||
| Pozen, Inc. (NASDAQ: POZN) | Delayed: 5.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.94 | 52 Week High | $12.69 | |||
| Open | $4.62 | 52 Week Low | $5.49 | |||
| Day High | $5.94 | P/E | N/A | |||
| Day Low | $5.94 | EPS | $-0.68 | |||
| Volume | 397,966 | |||||
